Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Trading Statement

27 Apr 2017 07:00

RNS Number : 4698D
Kingspan Group PLC
27 April 2017
 

Kingspan Group Plc

Trading Update

 

27 April 2017

 

Kingspan Group plc, the global leader in high performance insulation, building fabric, and solar integrated building envelopes, is issuing this Trading Update in advance of its Annual General Meeting which is being held today at 10.00am in Dublin.

Overall, Kingspan has experienced a good start to the year reflecting a combination of solid underlying markets and the acquisitions made in 2016 bedding down well. Group sales of €831.2m for the three month period to 31 March were 24% ahead of prior year (+26% pre-currency, +14% pre currency and acquisitions).

 

By market, the UK remains solid overall although is a little softer than at the turn of the year. Mainland European markets continue to show signs of recovery with decent volumes overall. The US market is a little more encouraging than conditions experienced towards the end of last year. The Middle East and Turkey regions are subdued, with Australia and its adjacent markets showing more positive signs. A feature of all markets has been ongoing raw material inflation and the associated recovery effort.

 

Insulated Panel sales revenues were up 32% (+33% pre-currency, +16% pre-currency and acquisitions). Volumes in most key end markets are positive with the key trading priority being margin. Light & Air contributed 6% to divisional sales in the quarter, on plan, and is an excellent addition to the Group's high performance product suite.

Insulation Board sales revenues were up 8% (+11% pre-currency) in the period. The Kooltherm® mix has been positive overall with raw material inflation experienced in all territories and the associated recovery underway. The Group's new Kooltherm® facility for the Australasian market was successfully commissioned in Melbourne during the period.

 

Access Floors sales revenues were up 6% (+8% pre-currency). US activity is subdued, as was the case last year. The UK is holding up well for the moment although the pipeline is indicating weakness towards the end of 2017.

 

Environmental sales revenues were up 13% (+21% pre-currency, 3% pre currency and acquisitions). Overall, the division has had a good start to the year with the Rainwater harvesting business in Australia a particular highlight.

 

Net debt at 31 March was €457m, an increase of €29m from the position at last year end reflecting, in the main, the seasonal investment in working capital. The Group's funding position is robust with €639m of committed undrawn facilities and cash balances.

 

Looking ahead, the order backlog across the Group overall points towards a solid first half for the business. The project pipeline is encouraging in most of our major markets, although trending weaker in the U.K. in recent weeks. The key trading priority is the pass through of increases in input costs, and the associated lag likely to persist in a tight supply environment into the second quarter, and perhaps beyond. As a consequence, likely sales growth in the first half is expected to outpace profit growth in the period. Overall, the Group remains well positioned given the breadth of our product and market mix, our development agenda over time, together with the ongoing advancement of our high performance technology.

 

Kingspan will issue its half-year financial report for the period ended 30 June 2017 on Friday 18 August 2017.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDQLFLDZFBBBZ
Date   Source Headline
24th Nov 201410:22 amRNSHolding(s) in Company
18th Nov 20144:49 pmRNSHolding(s) in Company
11th Nov 201412:48 pmRNSAcquisition
10th Nov 20147:00 amRNSInterim Management Statement
6th Nov 20149:35 amRNSHolding(s) in Company
3rd Nov 201411:15 amRNSTotal Voting Rights
3rd Nov 20147:00 amRNSAcquisition update
14th Oct 201410:11 amRNSHolding(s) in Company
2nd Oct 20145:09 pmRNSDirector/PDMR Shareholding
1st Oct 201411:00 amRNSTotal Voting Rights
29th Sep 20143:00 pmRNSHolding(s) in Company
12th Sep 201412:00 pmRNSDirector/PDMR Shareholding
8th Sep 20147:00 amRNSMain Securities Market Notice
2nd Sep 20145:01 pmRNSBlock Listing Application
1st Sep 201410:22 amRNSTotal Voting Rights
28th Aug 20145:59 pmRNSHolding(s) in Company
26th Aug 20147:00 amRNSHalf Yearly Report
18th Aug 20142:30 pmRNSHolding(s) in Company
18th Aug 201410:26 amRNSHolding(s) in Company
18th Aug 20147:00 amRNSAcquisition
30th Jul 20143:42 pmRNSHolding(s) in Company
29th Jul 20143:07 pmRNSHolding(s) in Company
3rd Jul 201412:39 pmRNSHolding(s) in Company
1st Jul 20142:50 pmRNSBlocklisting Interim Review
1st Jul 201410:45 amRNSTotal Voting Rights
23rd Jun 201410:48 amRNSDirector/PDMR Shareholding Replacement
19th Jun 20144:43 pmRNSDirector/PDMR Shareholding
19th Jun 201412:56 pmRNSDirector/PDMR Shareholding
19th Jun 201410:12 amRNSHolding(s) in Company
3rd Jun 20141:07 pmRNSDirector/PDMR Shareholding
3rd Jun 201410:36 amRNSTotal Voting Rights
22nd May 201412:22 pmRNSDirector/PDMR Shareholding
1st May 20143:32 pmRNSDirectorate Change
1st May 201410:39 amRNSAGM Results
1st May 20148:00 amRNSTotal Voting Rights
1st May 20147:00 amRNSInterim Management Statement
10th Apr 20144:39 pmRNSDirector/PDMR Shareholding
3rd Apr 201410:27 amRNSHolding(s) in Company
2nd Apr 20149:59 amRNSTotal Voting Rights
28th Mar 20146:30 pmRNSAnnual Financial Report
28th Mar 20147:01 amRNSSuccessful extension and re-pricing of EUR300m RCF
6th Mar 20144:49 pmRNSDirector/PDMR Shareholding
4th Mar 20144:06 pmRNSDirector/PDMR Shareholding
3rd Mar 201410:28 amRNSTotal Voting Rights
26th Feb 20145:27 pmRNSDirector/PDMR Shareholding
26th Feb 20143:48 pmRNSHolding(s) in Company
25th Feb 201412:52 pmRNSDirector/PDMR Shareholding
24th Feb 20147:00 amRNSFinal Results
24th Feb 20147:00 amRNSMain Securities Market Notice
21st Feb 20143:35 pmRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.